CL Financial Statements & Analysis
Complete financial statements for CL including income statement, balance sheet, and cash flow statement. Analyze CL's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
48
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
3.3% ↑
Net Income
25.6% ↑
Gross Margin
4.2% ↑
Operating Margin
2.7% ↑
Balance Sheet
Current Ratio
-17.1% ↓
Debt to Equity
169.8% ↓
Asset Turnover
5.5% ↑
Cash Flow
Operating Cash Flow
9.7% ↑
Net Cash Flow
-31.9% ↓
Free Cash Flow
16.6% ↑
Cash Flow to Debt
16.8% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 19.46B | 20.10B | 3.3% | |
| Gross Profit | 11.25B | 12.11B | 7.6% | |
| Operating Income | 4.13B | 4.38B | 6.1% | |
| Net Income | 2.30B | 2.89B | 25.6% | |
| EPS | 2.78 | 3.53 | 27.0% | |
| EBITDA | 4.25B | 4.85B | 14.3% | |
| Gross Margin | 57.82% | 60.23% | 4.2% | |
| Operating Margin | 21.23% | 21.80% | 2.7% | |
| Net Income Margin | 11.82% | 14.37% | 21.6% | |
| R&D Expenses | 343.00M | 355.00M | 3.5% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 20.10B | 19.46B | 17.97B | 17.42B | 16.47B |
| Gross Profit | 12.11B | 11.25B | 10.15B | 10.29B | 9.93B |
| Operating Income | 4.38B | 4.13B | 3.58B | 3.89B | 3.91B |
| Net Income | 2.89B | 2.30B | 1.78B | 2.17B | 2.69B |
| EPS | 3.53 | 2.78 | 2.13 | 2.56 | 3.15 |
| EBITDA | 4.85B | 4.25B | 3.37B | 3.76B | 4.35B |
| Gross Margin | 60.23% | 57.82% | 56.49% | 59.08% | 60.31% |
| Operating Margin | 21.80% | 21.23% | 19.95% | 22.31% | 23.74% |
| Net Income Margin | 14.37% | 11.82% | 9.93% | 12.43% | 16.36% |
| R&D Expenses | 355.00M | 343.00M | 320.00M | 307.00M | 290.00M |